| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Recombinant Human TREML2/TLT-2 Fc Chimera Protein, CF |
|---|
| Description | Purity >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 75-100 kDa, reducing conditions. MW (theoretical): 53.7 kDa (monomer). The Recombinant Human TREML2/TLT-2 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human TREML2/TLT-2 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | C6orf76, dJ238O23.1, FLJ13693, MGC149715, MGC149716, TLT2, TLT-2, trem-like transcript 2 protein, triggering receptor expressed on myeloid cells-like 2, triggering receptor expressed on myeloid cells-like protein 2, UNQ6268/PRO20473 |
|---|
| Gene, Accession, CAS # | TREML2, Gene ID: 79865, Accession: CAI19909 |
|---|
| Catalog # | 3259-TL-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human TREML2/TLT-2 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 22573805, 23555261 |
|---|
| 產(chǎn)品資料 |
|
|